Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
35.7%
% of MEDX's 28 holdings also in PJP
34.5%
% of PJP's 29 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.1% | 5.5% | 5.5% |
|
AMGEN INC | 6.1% | 5.1% | 5.1% |
|
ABBVIE INC | 9.1% | 5.0% | 5.0% |
|
JOHNSON & JOHNSON | 4.9% | 5.0% | 4.9% |
|
PFIZER INC | 3.9% | 5.1% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
|
ELI LILLY & CO | 11.5% |
 |
NOVARTIS AG-ADR | 7.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.8% |
|
ALNYLAM PHARMACEUTICALS INC | 5.5% |
 |
ALKERMES PLC | 4.3% |
|
ABBVIE INC | 4.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.9% |
|
IONIS PHARMACEUTICALS, INC. | 2.8% |
|
CRISPR THERAPEUTICS AG | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% |
MEDX Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.0% |
|
GILEAD SCIENCES INC | -4.9% |
|
OCULAR THERAPEUTIX INC | -3.3% |
|
INNOVIVA, INC. | -3.0% |
|
LIGAND PHARMACEUTICALS-CL B | -2.9% |
|
BIOSANTE PHARMACEUTICALS INC | -2.9% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.8% |
|
AMPHASTAR PHARMACEUTICALS INC | -2.7% |
|
JAZZ PHARMACEUTICALS PLC | -2.6% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.6% |